The Department of Defense Office Inspector General’s investigation found a lack of control over the handling of controlled medications within the White House Medical Unit under former President Donald Trump, leading to potential safety risks and high costs.
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.